Clinical Trials Browser

Phase EARLY_PHASE1 × Immune Checkpoint Inhibitors × 90 days × Clear all

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT07349836 2026-01-20

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Phase EARLY_PHASE1 Not yet recruiting

EBV-associated Tumors